{
  "variants": [
    {
      "variant_id": "rs34637584",
      "gene": "LRRK2",
      "protein_change": "G2019S",
      "variant_string": "LRRK2 G2019S",
      "functional_evidence": {
        "step_1": {
          "disease_mechanism": "LRRK2 variants are associated with PD risk, with kinase activity as a relevant mechanism.",
          "judgment": "Yes"
        },
        "step_2": {
          "assay_applicability": "Kinase activity assay is relevant to PD pathogenesis.",
          "judgment": "Yes"
        },
        "step_3": {
          "substep_3a": {
            "controls_used": "Wild-type control used, but no explicit 'Abnormal/Positive/Null' controls mentioned.",
            "judgment": "Not met"
          },
          "substep_3b": {
            "assay_accepted": "Kinase activity assay is a standard method in the field.",
            "judgment": "Yes",
            "strength": "Max PS3_supporting"
          }
        },
        "step_4": {
          "substep_4a": {
            "statistical_analysis": "Relative risk values (e.g., 1.9) suggest statistical significance.",
            "judgment": "Yes"
          },
          "substep_4c": {
            "odds_path": "Relative risk of 1.9 corresponds to PS3_supporting (OddsPath > 2.0).",
            "strength": "PS3_supporting"
          }
        }
      }
    },
    {
      "variant_id": "rs34778348",
      "gene": "LRRK2",
      "protein_change": "G2385R",
      "variant_string": "LRRK2 G2385R",
      "functional_evidence": {
        "step_1": {
          "disease_mechanism": "LRRK2 variants are associated with PD risk, with kinase activity as a relevant mechanism.",
          "judgment": "Yes"
        },
        "step_2": {
          "assay_applicability": "Kinase activity assay is relevant to PD pathogenesis.",
          "judgment": "Yes"
        },
        "step_3": {
          "substep_3a": {
            "controls_used": "Wild-type control used, but no explicit 'Abnormal/Positive/Null' controls mentioned.",
            "judgment": "Not met"
          },
          "substep_3b": {
            "assay_accepted": "Kinase activity assay is a standard method in the field.",
            "judgment": "Yes",
            "strength": "Max PS3_supporting"
          }
        },
        "step_4": {
          "substep_4a": {
            "statistical_analysis": "Relative risk values (e.g., 1.9) suggest statistical significance.",
            "judgment": "Yes"
          },
          "substep_4c": {
            "odds_path": "Relative risk of 1.9 corresponds to PS3_supporting (OddsPath > 2.0).",
            "strength": "PS3_supporting"
          }
        }
      }
    },
    {
      "variant_id": "rs34778348",
      "gene": "LRRK2",
      "protein_change": "R1628P",
      "variant_string": "LRRK2 R1628P",
      "functional_evidence": {
        "step_1": {
          "disease_mechanism": "LRRK2 variants are associated with PD risk, with kinase activity as a relevant mechanism.",
          "judgment": "Yes"
        },
        "step_2": {
          "assay_applicability": "Kinase activity assay is relevant to PD pathogenesis.",
          "judgment": "Yes"
        },
        "step_3": {
          "substep_3a": {
            "controls_used": "Wild-type control used, but no explicit 'Abnormal/Positive/Null' controls mentioned.",
            "judgment": "Not met"
          },
          "substep_3b": {
            "assay_accepted": "Kinase activity assay is a standard method in the field.",
            "judgment": "Yes",
            "strength": "Max PS3_supporting"
          }
        },
        "step_4": {
          "substep_4a": {
            "statistical_analysis": "Relative risk values (e.g., 1.9) suggest statistical significance.",
            "judgment": "Yes"
          },
          "substep_4c": {
            "odds_path": "Relative risk of 1.9 corresponds to PS3_supporting (OddsPath > 2.0).",
            "strength": "PS3_supporting"
          }
        }
      }
    },
    {
      "variant_id": "rs34778348",
      "gene": "LRRK2",
      "protein_change": "R1398H",
      "variant_string": "LRRK2 R1398H",
      "functional_evidence": {
        "step_1": {
          "disease_mechanism": "LRRK2 variants are associated with PD risk, with kinase activity as a relevant mechanism.",
          "judgment": "Yes"
        },
        "step_2": {
          "assay_applicability": "Kinase activity assay is relevant to PD pathogenesis.",
          "judgment": "Yes"
        },
        "step_3": {
          "substep_3a": {
            "controls_used": "Wild-type control used, but no explicit 'Abnormal/Positive/Null' controls mentioned.",
            "judgment": "Not met"
          },
          "substep_3b": {
            "assay_accepted": "Kinase activity assay is a standard method in the field.",
            "judgment": "Yes",
            "strength": "Max PS3_supporting"
          }
        },
        "step_4": {
          "substep_4a": {
            "statistical_analysis": "Relative risk values (e.g., 1.5-1.6) suggest statistical significance.",
            "judgment": "Yes"
          },
          "substep_4c": {
            "odds_path": "Relative risk of 1.5-1.6 corresponds to PS3_supporting (OddsPath > 2.0).",
            "strength": "PS3_supporting"
          }
        }
      }
    },
    {
      "variant_id": "rs34778348",
      "gene": "LRRK2",
      "protein_change": "N551K",
      "variant_string": "LRRK2 N551K",
      "functional_evidence": {
        "step_1": {
          "disease_mechanism": "LRRK2 variants are associated with PD risk, with kinase activity as a relevant mechanism.",
          "judgment": "Yes"
        },
        "step_2": {
          "assay_applicability": "Kinase activity assay is relevant to PD pathogenesis.",
          "judgment": "Yes"
        },
        "step_3": {
          "substep_3a": {
            "controls_used": "Wild-type control used, but no explicit 'Abnormal/Positive/Null' controls mentioned.",
            "judgment": "Not met"
          },
          "substep_3b": {
            "assay_accepted": "Kinase activity assay is a standard method in the field.",
            "judgment": "Yes",
            "strength": "Max BS3_supporting"
          }
        },
        "step_4": {
          "substep_4a": {
            "statistical_analysis": "Relative risk reduction when combined with other variants suggests protective effect.",
            "judgment": "Yes"
          },
          "substep_4c": {
            "odds_path": "Relative risk reduction corresponds to BS3_supporting (OddsPath < 1.0).",
            "strength": "BS3_supporting"
          }
        }
      }
    }
  ]
}